Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes.

Bang-Berthelsen CH, Pedersen L, Fløyel T, Hagedorn PH, Gylvin T, Pociot F.

BMC Genomics. 2011 Feb 4;12:97. doi: 10.1186/1471-2164-12-97.

3.

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.

Davidson JA, Liebl A, Christiansen JS, Fulcher G, Ligthelm RJ, Brown P, Gylvin T, Kawamori R.

Clin Ther. 2009 Aug;31(8):1641-51. doi: 10.1016/j.clinthera.2009.08.011.

PMID:
19808125
4.

Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.

Raskin P, Gylvin T, Weng W, Chaykin L.

Diabetes Metab Res Rev. 2009 Sep;25(6):542-8. doi: 10.1002/dmrr.989.

PMID:
19565569
5.

Functional SOCS1 polymorphisms are associated with variation in obesity in whites.

Gylvin T, Ek J, Nolsøe R, Albrechtsen A, Andersen G, Bergholdt R, Brorsson C, Bang-Berthelsen CH, Hansen T, Karlsen AE, Billestrup N, Borch-Johnsen K, Jørgensen T, Pedersen O, Mandrup-Poulsen T, Nerup J, Pociot F.

Diabetes Obes Metab. 2009 Mar;11(3):196-203. doi: 10.1111/j.1463-1326.2008.00900.x.

PMID:
19215277
6.

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group.

Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951 .

PMID:
19210140
7.
8.

Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity.

Gylvin T, Nolsøe R, Hansen T, Nielsen EMD, Bergholdt R, Karlsen AE, Billestrup N, Borch-Johnsen K, Pedersen O, Mandrup-Poulsen T, Nerup J, Pociot F.

Diabetologia. 2004 Jul;47(7):1273-1277. doi: 10.1007/s00125-004-1440-5. Epub 2004 Jul 13.

PMID:
15249995
9.

Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families.

Gylvin T, Bergholdt R, Nerup J, Pociot F.

Genes Immun. 2002 Nov;3(7):430-2.

Supplemental Content

Loading ...
Support Center